Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children between two ...

(Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the ...

A new scientific trial evaluating Bavarian Nordic’s mpox vaccine in pregnant and breastfeeding women and infants is set to launch in the Democratic Republic of Congo (DRC). This research could expand ...

To safeguard against additional cases, either at home or while deployed, the Defense Health Agency and the services have made ...

Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccine development, jettisoning its stake in shots targeting human papillomavirus (HPV) and hepatitis B virus (HBV).

In September, after facing criticism on moving too slowly on vaccines, the World Health Organization cleared Bavarian Nordic's vaccine for mpox and said it was considering LC16, made by Japan's KM ...

(Reuters) -The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to ...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety between teenagers and adults in an NIH study.

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the ...

In September, after facing criticism on moving too slowly on vaccines, the World Health Organization cleared Bavarian ...